Navigation Links
DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
Date:4/25/2013

Chicago, IL (PRWEB) April 25, 2013

The drug safety advocates at DrugRisk.com are alerting patients taking the blood thinner Pradaxa of updated legal news on the site. A federal judge overseeing hundreds of lawsuits alleging Pradaxa internal bleeding has asked lawyers to prepare a small number of cases for evidence gathering and early test trials.

The goal of DrugRisk is to improve patient safety by sharing the latest warnings, recalls, studies and legal news related to prescription drugs. Visitors can see if others are experiencing similar side effects and if legal action is under way.

Pradaxa was launched in 2010 to prevent strokes in patients with atrial fibrillation. Experts, however, have disagreed over whether it presents dangerous risks for internal bleeding. The FDA recently advised that Pradaxa is no more dangerous than traditional blood thinner warfarin*.

The Institute for Safe Medication Practices, however, warned that patients suffering Pradaxa bleeding are nearly 5 times as likely to die than those with bleeding from warfarin. They also named anticoagulants like Pradaxa among the most dangerous drugs**.

With over 260 patients so far having filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugRisk has added a Case Management Order from Judge David Herndon, who is overseeing the litigation, asking that lawyers prepare 16 cases for early discovery and the selection of early trials, or “bellwether” cases***.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

For more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2323437.0.pdf#search="pradaxa"

Read the full story at http://www.prweb.com/releases/side-effects-of-pradaxa/2013-pradaxa-lawsuit/prweb10669308.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
2. DrugRisk Announces Launch of Byetta Cancer Resource Center
3. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
4. DrugRisk Announces Addition of Januvia Cancer Resource Center
5. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
6. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
7. DrugRisk Announces Launch of DePuy Hip Resource Center
8. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
9. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
10. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
11. DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: